BIOGENERA SpA’s current pipeline reflects the company’s strong commitment to research in highly specialized areas with significant medical needs: cancer, metabolic disorders, and dermatological diseases. BIOGENERA SpA is actively developing multiple gene-specific molecules capable of revolutionizing treatments and improving patients’ lives.